Jean-Marie Michot, MD, discusses the phase 3 Olympia-3 study
The phase 3 trial evaluated the safety and efficacy of odronextamab, a CD20xCD3 bispecific antibody, in combination with CHOP chemotherapy for patients with
Lymphoma
Aggressive B-Cell Lymphomas
ASH 2025
News
Lymphoma
Indolent B-Cell Lymphomas
News
Australia TGA approves tafasitamab combo in relapsed, refractory FL
The phase 3 inMIND trial evaluated the efficacy and safety of tafasitamab in combination with rituximab and lenalidomide in adult patients with relapsed
Leukemia
Acute Myeloid Leukemia
News
Biosimilar filgrastim-laha receives FDA approval
Accord BioPharma, the therapy's manufacturer, expects a permanent Q-code from the US Centers for Medicare & Medicaid Services.
Ambassador Program
News
Society Updates
SOHO strengthens global leadership in blood cancer research
As we approach the end of the first quarter of 2026, I am pleased to share a brief update on the exceptional successes
Leukemia
Acute Myeloid Leukemia
SOHO Asia 2026
News
Video Interviews
Dr. Feng-Ming Tien on immune landscapes and the future of AML risk stratification
In this video interview from SOHO Asia 2026, Dr. Feng-Ming Tien discusses the critical link between the immune microenvironment and therapeutic success in
Cellular Therapy
Multiple Myeloma
News
Japan’s PMDA clears phase 3 trial of eque-cel in relapsed or refractory MM
The clearance allows the expansion of an international, phase 3 trial (CT103AC004) into Japan. This multi-center study evaluates the efficacy and safety of
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
CAR-T improves survival, reduces hospital use in R/R LBCL
The retrospective, single-center cohort study used linked data from the Princess Margaret Cancer Centre lymphoma database.
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Mantle Cell Lymphoma
T-Cell Lymphoma
SOHO 2026
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Society Updates
Registration now open for SOHO 2026
Registration is now officially open for the Fourteenth Annual Meeting of the Society of Hematologic Oncology. The event is scheduled for September 9
Community Oncology News
Community Oncology
Cellular Therapy
Multiple Myeloma
Video Interviews
Dr. Jeffrey Matous on managing access to novel agents in the community setting
Live session held on March 18, 2026, from 2:30 – 3 pm CT with speaker Jeffrey Matous presenting on "Managing access to novel
Lymphoma
Aggressive B-Cell Lymphomas
News
EC approves nivolumab and BV for relapsed or refractory cHL
The European Commission (EC) has approved nivolumab (Opdivo®) in combination with brentuximab vedotin for the treatment of adult and pediatric patients with relapsed